EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection
NCT02689518
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Macular Degeneration
Wet Macular Degeneration
Interventions
DRUG:
Intravitreal aflibercept injection
Sponsor
University of California, San Diego
Collaborators
[object Object]